CureVac NV
NASDAQ:CVAC

Watchlist Manager
CureVac NV Logo
CureVac NV
NASDAQ:CVAC
Watchlist
Price: 2.96 USD 3.14% Market Closed
Market Cap: 664m USD
Have any thoughts about
CureVac NV?
Write Note

Intrinsic Value

CVAC's intrinsic value estimate is unreliable because it is based only on its multiples and doesn't use a DCF valuation.

The intrinsic value of one CVAC stock under the Base Case scenario is 4.32 USD. Compared to the current market price of 2.96 USD, CureVac NV is Undervalued by 32%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

CVAC Intrinsic Value
4.32 USD
Undervaluation 32%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation History
CureVac NV

Intrinsic Value History
Dive into the past to invest in the future

Uncover deeper insights with the Valuation History. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start now and learn if your stock is truly undervalued or overvalued!

Start Valuation
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
Register to View Results
Register to View Results

To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.

Valuation History Unavailable

Historical valuation for CVAC cannot be conducted due to limitations such as insufficient data or other constraints.

Valuation In Progress...
Valuation In Progress...
How do you feel about CVAC?
Bearish
Neutral
Bullish

Fundamental Analysis

2.96 USD
+3.14%
+3.14%
Benchmark
Company Quality
No Indicators Selected
Select Indicators

Select up to 3 indicators:

Insider Trading
0-3
Months
0-6
Months
0-12
Months
0-36
Months
No Periods Selected
Select Periods

Select up to 2 periods:

CureVac NV
DE
Biotechnology
Market Cap
664m USD
IPO
Aug 14, 2020
Employees
500
Germany
Market Cap
664m USD
Industry
Biotechnology
IPO
Aug 14, 2020
Company Overview
Loading...
Economic Moat
Loading...
Earnings Call
Loading...
Management
Loading...
Contacts
Loading...
AI Assistant
AI Assistant
Ask me anything about CureVac NV

Provide an overview of the primary business activities
of CureVac NV.

What unique competitive advantages
does CureVac NV hold over its rivals?

What risks and challenges
does CureVac NV face in the near future?

Summarize the latest earnings call
of CureVac NV.

What significant events have occurred
in CureVac NV over the past months?

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for CureVac NV.

Provide P/S
for CureVac NV.

Provide P/E
for CureVac NV.

Provide P/OCF
for CureVac NV.

Provide P/FCFE
for CureVac NV.

Provide P/B
for CureVac NV.

Provide EV/S
for CureVac NV.

Provide EV/GP
for CureVac NV.

Provide EV/EBITDA
for CureVac NV.

Provide EV/EBIT
for CureVac NV.

Provide EV/OCF
for CureVac NV.

Provide EV/FCFF
for CureVac NV.

Provide EV/IC
for CureVac NV.

Show me price targets
for CureVac NV made by professional analysts.

What are the Revenue projections
for CureVac NV?

How accurate were the past Revenue estimates
for CureVac NV?

What are the Net Income projections
for CureVac NV?

How accurate were the past Net Income estimates
for CureVac NV?

What are the EPS projections
for CureVac NV?

How accurate were the past EPS estimates
for CureVac NV?

What are the EBIT projections
for CureVac NV?

How accurate were the past EBIT estimates
for CureVac NV?

Compare the revenue forecasts
for CureVac NV with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of CureVac NV and its key competitors using the latest financial data.

Compare historical revenue growth rates
of CureVac NV against its competitors.

Analyze the profit margins
(gross, operating, and net) of CureVac NV compared to its peers.

Compare the P/E ratios
of CureVac NV against its peers.

Discuss the investment returns and shareholder value creation
comparing CureVac NV with its peers.

Analyze the financial leverage
of CureVac NV compared to its main competitors.

Show all profitability ratios
for CureVac NV.

Provide ROE
for CureVac NV.

Provide ROA
for CureVac NV.

Provide ROIC
for CureVac NV.

Provide ROCE
for CureVac NV.

Provide Gross Margin
for CureVac NV.

Provide Operating Margin
for CureVac NV.

Provide Net Margin
for CureVac NV.

Provide FCF Margin
for CureVac NV.

Show all solvency ratios
for CureVac NV.

Provide D/E Ratio
for CureVac NV.

Provide D/A Ratio
for CureVac NV.

Provide Interest Coverage Ratio
for CureVac NV.

Provide Altman Z-Score Ratio
for CureVac NV.

Provide Quick Ratio
for CureVac NV.

Provide Current Ratio
for CureVac NV.

Provide Cash Ratio
for CureVac NV.

What is the historical Revenue growth
over the last 5 years for CureVac NV?

What is the historical Net Income growth
over the last 5 years for CureVac NV?

What is the current Free Cash Flow
of CureVac NV?

Discuss the annual earnings per share (EPS)
trend over the past five years for CureVac NV.

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
CureVac NV

Current Assets 584.7m
Cash & Short-Term Investments 554.9m
Receivables 11.8m
Other Current Assets 18m
Non-Current Assets 269.5m
PP&E 241.5m
Intangibles 26.2m
Other Non-Current Assets 1.8m
Current Liabilities 94.4m
Accounts Payable 13.4m
Other Current Liabilities 80.9m
Non-Current Liabilities 35.1m
Long-Term Debt 34.9m
Other Non-Current Liabilities 244k
Efficiency

Earnings Waterfall
CureVac NV

Revenue
543.3m EUR
Cost of Revenue
-157.9m EUR
Gross Profit
385.3m EUR
Operating Expenses
-253.1m EUR
Operating Income
132.2m EUR
Other Expenses
-23.9m EUR
Net Income
108.3m EUR

Free Cash Flow Analysis
CureVac NV

Last Value
3-Years Average
FCF Margin
Conversion Rate
Fundamental Scores

CVAC Profitability Score
Profitability Due Diligence

CureVac NV's profitability score is 32/100. The higher the profitability score, the more profitable the company is.

Exceptional Revenue Growth Forecast
Exceptional 1-Year Revenue Growth
ROE is Increasing
ROIC is Increasing
32/100
Profitability
Score

CureVac NV's profitability score is 32/100. The higher the profitability score, the more profitable the company is.

CVAC Solvency Score
Solvency Due Diligence

CureVac NV's solvency score is 99/100. The higher the solvency score, the more solvent the company is.

High Interest Coverage
High Altman Z-Score
Short-Term Solvency
Long-Term Solvency
99/100
Solvency
Score

CureVac NV's solvency score is 99/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

CVAC Price Targets Summary
CureVac NV

Wall Street analysts forecast CVAC stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for CVAC is 7.87 USD with a low forecast of 2.53 USD and a high forecast of 16.8 USD.

Lowest
Price Target
2.53 USD
15% Downside
Average
Price Target
7.87 USD
166% Upside
Highest
Price Target
16.8 USD
468% Upside
View Analyst Estimates
View Analyst Estimates
Want to learn more about Wall St estimates for CVAC?

Click here to dive deeper.

Dividends

CureVac NV
does not pay dividends
Shareholder Yield

Current shareholder yield for CVAC is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

CVAC News

Other Videos

See Also

Discover More
What is the Intrinsic Value of one CVAC stock?

The intrinsic value of one CVAC stock under the Base Case scenario is 4.32 USD.

Is CVAC stock undervalued or overvalued?

Compared to the current market price of 2.96 USD, CureVac NV is Undervalued by 32%.

Back to Top